[1]
|
马远征, 王以朋, 刘强, 等. 中国老年骨质疏松诊疗指南(2018) [J]. 中国老年学杂志, 2019, 39(11): 2557-2575.
|
[2]
|
白璧辉, 谢兴文, 李鼎鹏, 等. 我国近5年来骨质疏松症流行病学研究现状[J]. 中国骨质疏松杂志, 2018, 24(2): 253-258.
|
[3]
|
张银萍, 韦欢欢, 夏茹意, 等. 女性骨质疏松症生活质量简易评价问卷的本土化研究[J]. 护理研究, 2015, 29(34): 4245-4249.
|
[4]
|
Wang, B., Zhan, Y., Yan, L., et al. (2022) How Zoledronic Acid Im-proves Osteoporosis by Acting on Osteoclasts. Frontiers in Pharmacology, 13, Article ID: 961941. https://doi.org/10.3389/fphar.2022.961941
|
[5]
|
LeBoff, M.S., et al. (2022) The Clinician’s Guide to Prevention and Treatment of Osteoporosis. Osteoporosis International, 33, 2049-2102.
|
[6]
|
Compston, J., et al. (2017) UK Clini-cal Guideline for the Prevention and Treatment of Osteoporosis. Archives of Osteoporosis, 12, Article No. 43.
|
[7]
|
Fredrik, B., Linda, K., Gustav, O., et al. (2020) Fragility Fractures in Europe: Burden, Management and Op-portunities. Archives of Osteoporosis, 15, Article No. 59. https://doi.org/10.1007/s11657-020-0706-y
|
[8]
|
Giuseppe, R., Carmelinda, R., Luigi, M., et al. (2021) Osteoporo-sis in Men: A Review of an Underestimated Bone Condition. International Journal of Molecular Sciences, 22, Article No. 2105. https://doi.org/10.3390/ijms22042105
|
[9]
|
余晓波. 骨质疏松症的临床研究进展[J]. 中国医学创新, 2022, 19(21): 175-178.
|
[10]
|
杨芳芳, 马慧萍, 葸慧荣, 等. 骨质疏松症的病因病机研究概况[J]. 医学综述, 2017, 23(18): 3599-3603.
|
[11]
|
胡方元. 骨质疏松症须早预防早发现早治疗[N]. 大众健康报, 2022-07-26(012).
|
[12]
|
Bow, C.H., et al. (2012) Ethnic Difference of Clinical Vertebral Fracture Risk. Osteoporosis International, 23, 879-885.
|
[13]
|
Rolvien, T. and Amling, M. (2021) Disuse Osteoporosis: Clinical and Mechanistic In-sights. Calcified Tissue International, 110, 592-604. https://doi.org/10.1007/s00223-021-00836-1
|
[14]
|
Agostino, G., Pietra, P., Cornelia, B., et al. (2010) Increased Sclerostin Serum Levels Associated with Bone Formation and Resorp-tion Markers in Patients with Immobilization-Induced Bone Loss. The Journal of Clinical Endocrinology and Metabo-lism, 95, 2248-2253. https://doi.org/10.1210/jc.2010-0067
|
[15]
|
Hammond, E.R., Metcalf, H.M., Mcdonald, J.W., et al. (2014) Bone Mass in Individuals with Chronic Spinal Cord Injury: Associations with Activity-Based Therapy, Neurologic and Functional Status, a Retrospective Study. Archives of Physical Medicine and Rehabilitation, 95, 2342-2349. https://doi.org/10.1016/j.apmr.2014.07.395
|
[16]
|
Lora, G. and Neil, M. (2006) Bone Loss and Muscle Atrophy in Spinal Cord Injury: Epidemiology, Fracture Prediction, and Rehabilitation Strategies. The Journal of Spinal Cord Medicine, 29, 489-500.
https://doi.org/10.1080/10790268.2006.11753898
|
[17]
|
Giovanni, I., Marco, P., Sara, L., et al. (2019) Neuromus-cular Diseases and Bone. Frontiers in Endocrinology, 10, Article No. 794. https://doi.org/10.3389/fendo.2019.00794
|
[18]
|
Zerwekh, J.E., Ruml, L.A., Gottschalk, F. and Pak, C.Y. (1998) The Effects of Twelve Weeks of Bed Rest on Bone Histology, Biochemical Markers of Bone Turnover, and Calcium Homeostasis in Eleven Normal Subjects. Journal of Bone and Mineral Research, 13, 1594-1601.
|
[19]
|
Mariya, S., Nicholas, M., Tatsuya, C., et al. (2020) A Systematic Review and Meta-Analysis of Bone Loss in Space Travelers. NPJ Microgravity, 6, Article No. 13. https://doi.org/10.1038/s41526-020-0103-2
|
[20]
|
吴涵, 周文斌, 章雨帆, 等. 骨质疏松症治疗中维生素D的最佳水平及补充剂量的研究进展[J]. 中国骨质疏松杂志, 2020, 26(5): 731-736.
|
[21]
|
张宇, 李新, 张红梅, 等. 老年骨质疏松及伴有低钠血症骨质疏松患者的临床研究[J]. 中华老年医学杂志, 2017, 36(8): 872-876.
|
[22]
|
李晓玲, 汪靖峤, 付留俊. 维生素D滴剂辅助治疗骨质疏松症患者的效果及对骨代谢的影响[J]. 内科, 2021, 16(4): 446-449.
|
[23]
|
Bo, K., Dingjie, G, Baoming Y, et al. (2021) Dietary Carotenoid Intake and Osteoporosis: The National Health and Nutrition Examination Survey, 2005-2018. Archives of Osteoporosis, 17, Article No. 2.
https://doi.org/10.1007/s11657-021-01047-9
|
[24]
|
惠媛, 闫永鑫, 尹冬, 等. 2型糖尿病周围神经病变患者血清网膜素1水平与胰岛素抵抗相关性的研究[J]. 中国糖尿病杂志, 2021, 29(6): 453-456.
|
[25]
|
Nur-Vaizura, M., Nir-wana, S.I. and Kok-Yong, C. (2020) Are Oxidative Stress and Inflammation Mediators of Bone Loss Due to Estrogen Deficiency? A Review of Current Evidence. Endocrine, Metabolic & Immune Disorders Drug Targets, 20, 1478-1487.
|
[26]
|
应大文, 刘芳. 血清Omentin-1水平与2型糖尿病并发骨质疏松症的相关性研究[J]. 中国骨质疏松杂志, 2017, 23(2): 141-144.
|
[27]
|
Xie, H., et al. (2012) Omentin-1 Exerts Bone-Sparing Effect in Ovariectomized Mice. Osteoporosis International, 23, 1425-1436. https://doi.org/10.1007/s00198-011-1697-8
|
[28]
|
廖春梅, 颜玮茹. 高尿酸血症合并骨质疏松患者网膜素-1与骨密度及骨代谢指标的相关性[J]. 医药导报, 2022, 41(8): 1152-1156.
|
[29]
|
Tao, Z.B., et al. (2021) Pyroptosis in Osteoblasts: A Novel Hypothesis Underlying the Pathogenesis of Osteoporosis. Frontiers in Endocrinology, 11, Article ID: 548812. https://doi.org/10.3389/fendo.2020.548812
|
[30]
|
Srivastava, R.K., Dar, H.Y. and Mishra, P.K. (2018) Immunopo-rosis: Immunology of Osteoporosis—Role of T Cells. Frontiers in Immunology, 9, Article No. 657. https://doi.org/10.3389/fimmu.2018.00657
|
[31]
|
Kamiya, Y., Kikuchi, T., Goto, H., Okabe, I., et al. (2020) IL-35 and RANKL Synergistically Induce Osteoclastogenesis in RAW264 Mouse Monocytic Cells. International Journal of Molecular Sciences, 21, Article No. 2069.
https://doi.org/10.3390/ijms21062069
|
[32]
|
Martinis, M.D., Sirufo, M.M., Suppa, M., et al. (2020) IL-33/IL-31 Axis in Osteoporosis. International Journal of Molecular Sciences, 21, Article No. 1239. https://doi.org/10.3390/ijms21041239
|
[33]
|
Lia, G. and Massimo, D.M. (2016) Osteoimmunology and Beyond. Current Medicinal Chemistry, 23, 3754-3774.
https://doi.org/10.2174/0929867323666160907162546
|
[34]
|
Pignolo, R.J., Law, S.F. and Chandra, A. (2021) Bone Aging, Cellular Senescence, and Osteoporosis. JBMR Plus, 5, e10488. https://doi.org/10.1002/jbm4.10488
|
[35]
|
林露茜, 徐婷婷, 曹芹芹, 等. 铅对骨代谢生化指标影响的研究进展[J]. 畜牧与饲料科学, 2021, 42(5): 45-50.
|
[36]
|
Radojka, B., Snjezana, M. and Jagoda, B. (2017) Risk Factors for Osteoporosis in Postmenopausal Women. Medical Archives (Sarajevo, Bosnia and Herzegovina), 71, 25-28.
|
[37]
|
Korkor, A.B., Eastwood, D. and Bretzmann, C. (2009) Effects of Gender, Alcohol, Smoking, and Dairy Consumption on Bone Mass in Wisconsin Adolescents. WMJ: Official Publication of the State Medical Society of Wisconsin, 108, 181-188.
|
[38]
|
So, R. and Matsuo, T. (2020) The Ef-fect of Domain-Specific Sitting Time and Exercise Habits on Metabolic Syndrome in Japanese Workers: A Cross-Sectional Study. International Journal of Environmental Research and Public Health, 17, Article No. 3883. https://doi.org/10.3390/ijerph17113883
|
[39]
|
华诚峰, 潘佩婵, 利结芳, 等. 老年骨质疏松症合并2型糖尿病患者中医体质类型与生活习惯的相关性分析[J]. 齐鲁护理杂志, 2020, 26(3): 40-43.
|
[40]
|
Maurel, D.B., et al. (2012) Alcohol and Bone: Review of Dose Effects and Mechanisms. Osteoporosis International, 23, 1-16.
|
[41]
|
Zhang, X., Yu, Z., Yu, M. and Qu, X. (2015) Alcohol Consumption and Hip Fracture Risk. Osteoporosis International, 26, 531-542.
|
[42]
|
Iacopo, C., Alberto, F., Daniela, M., et al. (2020) Updates in Epidemiology, Pathophysiology and Man-agement Strategies of Glucocorticoid-Induced Osteoporosis. Expert Review of Endocrinology & Metabolism, 15, 283-298.
https://doi.org/10.1080/17446651.2020.1772051
|
[43]
|
Amiche, M.A., et al. (2016) Fracture Risk in Oral Glucocor-ticoid Users: A Bayesian Meta-Regression Leveraging Control Arms of Osteoporosis Clinical Trials. Osteoporosis In-ternational, 27, 1709-1718.
https://doi.org/10.1007/s00198-015-3455-9
|
[44]
|
Juliet, C. (2018) Glucocorticoid-Induced Osteoporosis: An Up-date. Endocrine, 61, 7-16.
https://doi.org/10.1007/s12020-018-1588-2
|
[45]
|
Yao, W., et al. (2016) Sclerostin-Antibody Treatment of Gluco-corticoid-Induced Osteoporosis Maintained Bone Mass and Strength. Osteoporosis International, 27, 283-294. https://doi.org/10.1007/s00198-015-3308-6
|
[46]
|
Liu, C.W. and Li, H. (2019) Correlation of the Severity of Chronic Kidney Disease with Serum Inflammation, Osteoporosis and Vitamin D Deficiency. Experimental and Therapeutic Med-icine, 17, 368-372.
|
[47]
|
刘军, 李娜, 王艳. 慢性肾衰竭血液透析患者FGF23水平与骨质疏松的关系[J]. 中国中西医结合肾病杂志, 2018, 19(8): 716-717.
|
[48]
|
Teaford, H.R., Barreto, J.N., Vollmer, K.J., et al. (2019) Cystatin C: A Primer for Pharmacists. Pharmacy, 8, Article No. 35. https://doi.org/10.3390/pharmacy8010035
|
[49]
|
Satoshi, T., Kei, A., Kazuyoshi, K., et al. (2019) Utility of the Serum Cystatin C Level for Diagnosis of Osteoporosis among Mid-dle-Aged and Elderly People. BioMed Research International, 2019, Article ID: 5046852.
https://doi.org/10.1155/2019/5046852
|
[50]
|
Franks, P.W. and Mccarthy, M.I. (2016) Exposing the Exposures Re-sponsible for Type 2 Diabetes and Obesity. Science, 354, 69-73. https://doi.org/10.1126/science.aaf5094
|
[51]
|
Leslie, W.D., Rubin, M.R., Schwartz, A.V., et al. (2012) Type 2 Diabetes and Bone. Journal of Bone and Mineral Research, 27, 2231-2237. https://doi.org/10.1002/jbmr.1759
|
[52]
|
Saeedi, P., Petersohn, I., Salpea, P., et al. (2019) Global and Regional Diabetes Prevalence Estimates for 2019 and Projections for 2030 and 2045: Results from the International Dia-betes Federation Diabetes Atlas, 9th Edition. Diabetes Research and Clinical Practice, 157, Article ID: 107843. https://doi.org/10.1016/j.diabres.2019.107843
|
[53]
|
Nicola, N., Manju, C., et al. (2017) Mechanisms of Diabetes Mellitus-Induced Bone Fragility. Nature Reviews Endocrinology, 13, 208-219. https://doi.org/10.1038/nrendo.2016.153
|
[54]
|
雷嫚嫚, 李卓, 郭蔚莹. 继发性骨质疏松发病机制[J]. 中国骨质疏松杂志, 2018, 24(11): 1514-1520.
|
[55]
|
穆卡达斯•艾尔肯, 徐迎胜. 抑郁症与骨质疏松关系的研究进展[J]. 山东医药, 2020, 60(4): 91-94.
|
[56]
|
王凯, 宋敏, 宋志靖, 等. 抑郁症与老年性骨质疏松之间的相关性[J]. 中国骨质疏松杂志, 2020, 26(5): 751-754+76.
|